Recent News

Tretinoin, a Derivative of Vitamin A, Could Improve the Anti-Cancer Effects of Chemotherapy on Mesothelioma

May 8, 2026

Tretinoin, a derivative of vitamin A, is showing potential to enhance the effects of chemotherapy. Combining tretinoin with chemotherapy improved survival rates in mesothelioma in mice. Mesothelioma is a rare[…]

Researchers are Trying to Figure Out Why Younger People are Getting Mesothelioma

May 1, 2026

A new study from Memorial Sloan Kettering Cancer Center is raising questions about who develops mesothelioma and why. Researchers identified 273 pleural mesothelioma patients at or under the age of[…]

Limited Surgery to Limit Symptoms of Pleural Mesothelioma

April 24, 2026

A new clinical trial at the University of Chicago is testing whether a smaller, symptom-focused surgery can help pleural mesothelioma patients maintain quality of life when tumor removal is not[…]

Radiomics to Determine Mesothelioma

April 17, 2026

Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Determining which patients will benefit from these treatments is important. Radiomics,[…]

Collapsed Lung and Mesothelioma

April 10, 2026

A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectantly. It often requires many clinical tests for accurate diagnosis and[…]

PITAC to Treat Mesothelioma

April 3, 2026

A Stanford team performed a specialized procedure for pleural mesothelioma for the very first time in North America. It is known as pressurized intrathoracic aerosol chemotherapy (PITAC), and it delivers[…]

Blood Test Did Not Reduce Late Stage Cancer Diagnoses

March 27, 2026

A major clinical trial found that a blood test designed to detect cancer early did not reduce the number of late-stage diagnoses. Grail, the manufacturer of the test, reported the[…]

Pleurectomy/Decortication Surgery Has Low Mortality When Patients are Carefully Selected

March 13, 2026

A new study out of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds lung-sparing pleurectomy/decortication (P/D) surgery has a very low rate[…]

Tumor Treating Fields to Treat Mesothelioma and Other Hard to Treat Cancers

March 6, 2026

Tumor treating fields are an innovative new way to treat cancer. They do not involve surgery or drugs. They are also known as TTFields. TTFields have been approved by the[…]

Artificial Intelligence and Mesothelioma

February 27, 2026

Diagnosing lung diseases can be hard because they have many causes and symptoms. Artificial intelligence may enable faster and more accurate diagnosis. AI could potentially play a role in improving[…]

Skip to content